Product: Avastin, 25MG/ML Syringe, [a) 0.1 mL NDC 70731-0197-91; b) 0.12 mL NDC 70731-0197-92; c) 0.15 mL NDC 70731-0197-93] per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701.
Reason for recall: Lack of Assurance of Sterility
Recall initiated: 20190619
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated